Answers are grounded in this paper and cite their sources.
Heat shock protein 47 (HSP47) acts as a collagen-specific molecular chaperone that is required for maturation of various types of collagens and is mainly expressed in fibroblasts and myofibroblasts in which collagen is constitutively expressed, synthesized and secreted. HSP47 plays an essential role in the development of fibrotic diseases such as liver cirrhosis and chronic pancreatitis, suggesting that HSP47 is a candidate as an anti-fibrotic therapeutic target. It has been reported that HSP47 is expressed in several cancer cells and that the increased expression of HSP47 is associated with poor prognosis and high malignant grade of tumors. Besides the role of HSP47 as a collagen-specific chaperone, it has recently been unveiled that HSP47 directly interacts with the unfolded protein response transducer IRE1α and that its interaction regulates cell fate, growth and metastasis of cancer cells. This review focuses on the recent findings of the role of HSP47 in cancer cells and discusses the possibility of HSP47 as a therapeutic target for cancer therapy.
No takes yet. Share an insight, caveat, or question.
Yoneda et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: